AMGN vs RLI · P/E 24, rev $10.05B vs P/E 24, rev $999.4M
Amgen Inc (AMGN) versus RLI Corp (RLI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
RLI Corp (RLI) is a insurance - property & casualty company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported RLI revenue for 2026-06-30 was $999.4M. Net income was $222.9M. RLI currently screens at market cap $6.58B and trailing P/E 23.7.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. RLI currently screens at market cap $6.58B and trailing P/E 23.7.
Not investment advice. Open the AMGN and RLI stock pages for the full models.
Not investment advice.